BackHemagen Diagnostics Overview

Hemagen Diagnostics Current Assets

Latest current assets for HMGN: $2.1M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$2.09M
↓ 14.47% YoYΔ $-354378.00 vs prior year quarter

Peer trimmed avg / median

Loading

Hemagen Diagnostics Current Assets History

Loading

Hemagen Diagnostics vs. peers: Current Assets Comparison

Loading

Hemagen Diagnostics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Hemagen Diagnostics (HMGN) FAQ

As of the most recent data (September 2012), HMGN shows a current assets of $2.1M. That compares with $2.4M in the prior-year period — down 14.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HMGN's current assets is now $2.1M (was $2.4M) — a 14.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Hemagen Diagnostics is outperforming or lagging.

Tracking HMGN's current assets over time shows whether Hemagen Diagnostics is scaling, shrinking, or reshaping that part of the business. The current reading is $2.1M That compares with $2.4M in the prior-year period — down 14.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Hemagen Diagnostics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $2.1M) with ownership activity and broader fundamentals.

Hemagen Diagnostics's current assets is $2.1M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.